Diclofenac Amide (CAS 15362-40-0)
QUICK LINKS
Diclofenac Amide is a chemical compound that functions as a nonsteroidal anti-inflammatory (NSAID) in experimental applications. It exerts its mechanism of action by inhibiting the activity of cyclooxygenase (COX) enzymes, COX-1 and COX-2, which are responsible for the production of prostaglandins from arachidonic acid. By blocking the action of these enzymes, diclofenac amide reduces the synthesis of prostaglandins, which are involved in the inflammatory response. This leads to a decrease in the production of inflammatory mediators, such as prostaglandins, thromboxanes, and prostacyclins, ultimately resulting in the alleviation of inflammation and pain.Diclofenac amide may exhibit analgesic and antipyretic properties, further contributing to its role as an NSAID in experimentalize. At the molecular level, diclofenac amide interacts with the active site of COX enzymes, preventing the conversion of arachidonic acid to prostaglandins, and thereby modulating the inflammatory response.
Diclofenac Amide (CAS 15362-40-0) References
- A tale of switched functions: from cyclooxygenase inhibition to M-channel modulation in new diphenylamine derivatives. | Peretz, A., et al. 2007. PLoS One. 2: e1332. PMID: 18159230
- In situ aqueous derivatization and determination of non-steroidal anti-inflammatory drugs by salting-out-assisted liquid-liquid extraction and gas chromatography-mass spectrometry. | Noche, GG., et al. 2011. J Chromatogr A. 1218: 6240-7. PMID: 21820666
- Methodology for profiling anti-androgen mixtures in river water using multiple passive samplers and bioassay-directed analyses. | Liscio, C., et al. 2014. Water Res. 57: 258-69. PMID: 24726995
- Determination of 4'-isobutylacetophenone and other transformation products of anti-inflammatory drugs in water and sludge from five wastewater treatment plants in Sweden by hollow fiber liquid phase microextraction and gas chromatography-mass spectrometry. | Manso, J., et al. 2014. Talanta. 125: 87-93. PMID: 24840419
- Behaviour of pharmaceuticals and personal care products in constructed wetland compartments: Influent, effluent, pore water, substrate and plant roots. | Hijosa-Valsero, M., et al. 2016. Chemosphere. 145: 508-17. PMID: 26702554
- Removal of ozonation products of pharmaceuticals in laboratory Moving Bed Biofilm Reactors (MBBRs). | El-Taliawy, H., et al. 2018. J Hazard Mater. 347: 288-298. PMID: 29329011
- Sono-activated persulfate oxidation of diclofenac: Degradation, kinetics, pathway and contribution of the different radicals involved. | Monteagudo, JM., et al. 2018. J Hazard Mater. 357: 457-465. PMID: 29935458
- Determination of polar organic micropollutants in surface and pore water by high-resolution sampling-direct injection-ultra high performance liquid chromatography-tandem mass spectrometry. | Posselt, M., et al. 2018. Environ Sci Process Impacts. 20: 1716-1727. PMID: 30350841
- Bacterial Diversity Controls Transformation of Wastewater-Derived Organic Contaminants in River-Simulating Flumes. | Posselt, M., et al. 2020. Environ Sci Technol. 54: 5467-5479. PMID: 32251587
- Ozone dose dependent formation and removal of ozonation products of pharmaceuticals in pilot and full-scale municipal wastewater treatment plants. | Kharel, S., et al. 2020. Sci Total Environ. 731: 139064. PMID: 32413657
- Statistical mechanics of DNA-nanotube adsorption. | Tonoyan, S., et al. 2020. Phys Rev E. 101: 062422. PMID: 32688493
- Hydrothermal liquefaction of sewage sludge; energy considerations and fate of micropollutants during pilot scale processing. | Silva Thomsen, LB., et al. 2020. Water Res. 183: 116101. PMID: 32777593
- Removal of pharmaceutical metabolites in wastewater ozonation including their fate in different post-treatments. | Kharel, S., et al. 2021. Sci Total Environ. 759: 143989. PMID: 33321442
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Diclofenac Amide, 5 g | sc-218184 | 5 g | $135.00 |